Latham-led Deal Shortlisted for the Scrip Awards’ Quris Best Partnership Alliance Honor
Healthcare and life sciences licensing and corporate deal teams advised on the transaction recognized for innovative industry collaboration.
Judith Hasko advises life sciences companies and investors on a wide range of technology-based commercial matters. Widely recognized for her market-leading transactional work, she currently serves as Vice Chair of Latham’s Healthcare & Life Sciences Practice.
Ms. Hasko represents companies developing biotechnology, pharmaceutical, medical device and diagnostic products, and their investors on matters, including:
Ms. Hasko brings complementary business and scientific perspectives to her legal representations. She is a Certified Licensing Professional (CLP), and a member of the Patent Bar. Prior to attending law school, she was part of Genentech’s cardiovascular research department.
She has co-authored several scientific publications and frequently lectures on life sciences commercial topics in both industry and academic settings, including at Berkeley Law and Stanford University.
Ms. Hasko's representative transactions include advising:
Healthcare and life sciences licensing and corporate deal teams advised on the transaction recognized for innovative industry collaboration.
Recognitions include Impact Deal of the Year and Patent Impact Case of the Year.
Firm awarded for excellence and innovation in the life science legal space.